Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1983
Intravesical chemotherapy of superficial bladder cancer
B L Lum
Clinical Pharmacology and Therapeutics
|
March 15, 2016
Should Therapeutic Drug Monitoring for Monoclonal Antibodies Remain the Exception or Become the Norm?
M Stroh, B L Lum
Cancer Treatment Reviews
|
December 1, 1985
Therapeutic approaches including interferon to carcinoma in situ of the bladder
B L Lum, F M Torti
Seminars in Oncology
|
September 1, 1986
Superficial carcinoma of the bladder: natural history and the role of interferons
F M Torti, B L Lum
Hematology/Oncology Clinics of North America
|
April 1, 1995
MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors
B L Lum, M P Gosland
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1984
The biology and treatment of superficial bladder cancer
F M Torti, B L Lum
Cancer
|
February 1, 1987
Superficial bladder cancer. Risk of recurrence and potential role for interferon therapy
F M Torti, B L Lum
Journal of the National Cancer Institute
|
May 15, 1991
Adjuvant intravesicular pharmacotherapy for superficial bladder cancer
B L Lum, F M Torti
Therapeutic Drug Monitoring
|
June 12, 1999
Prediction of valproate serum concentrations in adult psychiatric patients using Bayesian model estimations with NPEM2 population pharmacokinetic parameters
E Puentes, T Puzantian, B L Lum
Drug Intelligence & Clinical Pharmacy
|
April 1, 1986
Possible risk of invasive pulmonary aspergillosis with marijuana use during chemotherapy for small cell lung cancer
S Sutton, B L Lum, F M Torti
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1983
Intravesical chemotherapy of superficial bladder cancer
B L Lum
Clinical Pharmacology and Therapeutics
|
March 15, 2016
Should Therapeutic Drug Monitoring for Monoclonal Antibodies Remain the Exception or Become the Norm?
M Stroh, B L Lum
Cancer Treatment Reviews
|
December 1, 1985
Therapeutic approaches including interferon to carcinoma in situ of the bladder
B L Lum, F M Torti
Seminars in Oncology
|
September 1, 1986
Superficial carcinoma of the bladder: natural history and the role of interferons
F M Torti, B L Lum
Hematology/Oncology Clinics of North America
|
April 1, 1995
MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors
B L Lum, M P Gosland
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1984
The biology and treatment of superficial bladder cancer
F M Torti, B L Lum
Cancer
|
February 1, 1987
Superficial bladder cancer. Risk of recurrence and potential role for interferon therapy
F M Torti, B L Lum
Journal of the National Cancer Institute
|
May 15, 1991
Adjuvant intravesicular pharmacotherapy for superficial bladder cancer
B L Lum, F M Torti
Therapeutic Drug Monitoring
|
June 12, 1999
Prediction of valproate serum concentrations in adult psychiatric patients using Bayesian model estimations with NPEM2 population pharmacokinetic parameters
E Puentes, T Puzantian, B L Lum
Drug Intelligence & Clinical Pharmacy
|
April 1, 1986
Possible risk of invasive pulmonary aspergillosis with marijuana use during chemotherapy for small cell lung cancer
S Sutton, B L Lum, F M Torti
Page
of 6